Skip to main content

Advertisement

Table 1 Clinical characteristics of participants

From: Effects of green tea consumption on cognitive dysfunction in an elderly population: a randomized placebo-controlled study

  Placebo Green tea
Number of subjects 16 17
Age, mean ± SD 87.9 ± 5.6 81.8 ± 11.1
Sex, n (%)
 Men 1 (6.3) 3 (17.6)
 Women 15 (93.7) 14 (82.4)
BMI, mean ± SD 21.6 ± 3.3 22.6 ± 2.8
Underlying diseases, n (%)   
 Alzheimer’s disease 8 (50.0) 9 (52.9)
 Vascular dementia 8 (50.0) 7 (41.2)
 Dementia with Lewy bodies 0 (0.0) 1 (5.9)
CT/MRI
 CT 15 (93.8) 17 (100.0)
 CT, MRI 1 (6.2) 0 (0.0)
 MMSE-J score, mean ± SD 15.7 ± 4.4 15.9 ± 6.3
Complications, n (%)
 Hypertension 9 (56.3) 13 (76.5)
 Dyslipidaemia 7 (43.8) 3 (17.6)
 Diabetes 4 (25.0) 5 (29.4)
Concomitant drugs, n (%)
 Antihypertensive drugs 12 (75.0) 13 (76.5)
 Antidyslipidemic drugs 5 (31.3) 2 (11.8)
 Antidiabetic drugs 4 (25.0) 4 (23.5)
 Dementia therapeutic drugs 3 (18.8) 2 (11.8)
Activities of daily living, n (%)
 Independent 4 (25.0) 5 (29.4)
 Some assistance necessary 12 (75.0) 11 (64.7)
 Full assistance necessary 0 (0.0) 1 (5.9)
Daily tea consumption 16 (100.0) 17 (100.0)
 Green tea, n (%) 16 (100.0) 17 (100.0)
 Other, n (%) 5 (31.3) 7 (41.2)
Alcohol use, n (%) 0 (0.0) 1 (5.9)
Smoking, n (%) 1 (6.3) 2 (11.8)
Dietary supplement consumption, n (%) 0 (0.0) 0 (0.0)
  1. BMI body mass index, CT computed tomography, MRI Magnetic resonance imaging, MMSE-J Mini Mental State Examination Japanese version, SD standard deviation